|
Roldán V, Marín F. Oral anticoagulation in chronic kidney disease: A huge challenge. Thromb Haemost. 2012 Jul;108(1):3-5. doi: 10.1160/TH12-05-0324. Epub 2012 May 25. PubMed PMID: 22628077.
AÑO: 2012; IF: 6.094
|
22628077
|
Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. English, Spanish. PubMed PMID: 22609214.
AÑO: 2012; IF: 3.204
|
|
Marín F, Roldán V, Lip GY. Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable? Expert Opin Pharmacother. 2012 Jun;13(8):1087-90. doi: 10.1517/14656566.2012.688954. Epub 2012 May 9. PubMed PMID: 22568622.
AÑO: 2012; IF: 2.86
|
|
Manzano-Fernández S, Tello-Montoliu A, Marín F. Primary prevention with aspirin in type 2 diabetic patients. Searching for the right spot. Circ J. 2012;76(6):1333-4. Epub 2012 Apr 25. PubMed PMID: 22531598.
AÑO: 2012; IF: 3.578
|
|
Tello-Montoliu A, Jover E, Rivera J, Valdés M, Angiolillo DJ, Marín F. New perspectives in antiplatelet therapy. Curr Med Chem. 2012;19(3):406-27. Review. PubMed PMID: 22335515.
AÑO: 2012; IF: 4.07
|